Table 1.
SISAQOL statement | PROEAS item | Points |
---|---|---|
Taxonomy of research objectives (7 points) | ||
RS 1 | PRO endpoints were specified in the protocol | 1 |
Hypothesis requirement was met as neededa | 1 | |
Endpoints were used to make appropriate conclusionsb | 1 | |
RS 2 | Direction of the hypothesis was prespecified in the protocol if required | 1 |
Clinical relevance for between-group differences was prespecified in the protocol | 1 | |
RS 3–8 | Within-treatment group objective stated in the protocol | 1 |
Clinical relevance for within-patient or within–treatment group change was predefined in the protocol | 1 | |
Recommending statistical methods (6 points) | ||
RS 10 | Statistical test comparing 2 groups done when appropriate | 1 |
Provided P values for statistical significance | 1 | |
Tests used adjusted for baseline covariates | 1 | |
Tests used handled clustered data (repeated assessments) | 1 | |
Correction for multiple testing done appropriately | 1 | |
RS 11–15 | Used at least 1 appropriate statistical test to evaluate the tested outcomec | 1 |
Standardizing statistical terms related to missing data (6 points) | ||
RS 16 | A definition for missing data was reported | 1 |
RS 18 | Study did not consider PRO assessments for deceased patients as missing data | 1 |
RS 21–22 | Variable denominator rate reported | 1 |
RS 19–20 | Fixed denominator rate reported | 1 |
RS 23 | Absolute number for both numerators and denominators were reported | 1 |
A CONSORT diagram or table reporting reasons for treatment discontinuation was provided | 1 | |
General handling of missing data (5 points) | ||
RS 27 | Study documented a priori the approach for handling missing data | 1 |
RS 28 | Item-level missing data handled according to the scoring algorithm of the instrument | 1 |
RS 30 | A method that allows the use of all available data was used to approach missing data | 1 |
RS 31 | Study did not use explicit imputation methods unless justified | 1 |
RS 32 | At least 2 different approaches to handle missing data were used | 1 |
A hypothesis statement was required if PROs were a secondary endpoint and not required if PROs were an exploratory endpoint. CONSORT = Consolidated Standards of Reporting Trials; PRO = patient-reported outcome; PROEAS = Patient Reported Outcomes Endpoints Analysis Score; RS = recommended statement; SISAQOL = Standards in Analyzing Patient-Reported Outcomes and Quality of Life.
Comparative conclusions were considered appropriate if PROs were a primary or secondary endpoint only and inappropriate if PROs were exploratory endpoints.
Statistical tests were considered appropriate if they met the recommendations of the SISAQOL.